Skip to content

Prospective, multicenter, randomized controlled and non-inferior evaluation of the safety and effectiveness of intracranial embolectomy stent in endovascular treatment of acute ischemic stroke

Prospective, multicenter, randomized controlled and non-inferior evaluation of the safety and effectiveness of intracranial embolectomy stent in endovascular treatment of acute ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122252
Enrollment
Unknown
Registered
2026-04-10
Start date
2023-03-19
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

test team:Intracranial embolectomy stent
control group:Solitaire FR

Sponsors

The First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: General selection criteria: 1. >=18 years old; 2. NIHSS >= 6 at randomization; 3. Mrs =6 should be >= 6; 8. When it is more than 6 h but not more than 24 h (inclusive) from the onset of stroke to the completion of femoral artery puncture, refer to the imaging CTP/MRP in "Guidelines for Early Intravascular Interventional Diagnosis and Treatment of Acute Ischemic Stroke in China 2022" for evaluation, and at the same time meet ASPECTS >=6 points; 9.DSA showed acute occlusion of internal carotid artery, M1 and M2 segments of middle cerebral artery, A1 and A2 segments of anterior cerebral artery, basilar artery and vertebral artery.

Exclusion criteria

Exclusion criteria: General exclusion criteria: 1. Neither MRI nor CT can be performed; 2. Severe persistent hypertension that cannot be controlled by drug treatment, i.e. SBP lasting more than 185 mmHg and/or DBP lasting more than 110 mmHg;; 3. Blood sugar 22.20 mmol/L (400 mg/dl); 4. Decreased platelet count ( 1 vessel was occluded (for example, bilateral internal carotid arteries were occluded at the same time, or the intracranial vessels of anterior circulation and posterior circulation were occluded at the same time, or the intracranial and extracranial segments of internal carotid arteries were occluded at the same time, or the intracranial and extracranial segments of vertebrobasilar arteries were occluded at the same time); 15. Angiography showed intracranial arterial occlusion caused by arterial dissection or arteritis; 16. The blood vessels in the pathway are seriously tortuous, and it is difficult for the test/control instrument to reach the target position.

Design outcomes

Primary

MeasureTime frame
Immediate vascular recanalization success rate;

Secondary

MeasureTime frame
90 days after operation, mRS 0-2 score ratio.;The time from femoral artery puncture to vascular recanalization or the end time of surgery for subjects with no vascular recanalization.;Percentage of subjects whose NIHSS score decreased by > 4 points;Instrument operation success rate;Surgical success rate;Incidence of symptomatic intracranial hemorrhage in 24 hours after operation;Incidence of asymptomatic intracranial hemorrhage in 24 hours after operation;24 h after operation, all-cause mortality;All-cause mortality 90 days after operation;Incidence of adverse events and serious adverse events.;Incidence rate of instrument defects;

Countries

China

Contacts

Public ContactJianmin Liu

The First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital)

liu118@vip.163.com+86 139 0178 0638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026